| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/03/2008 | CA2655441A1 New compounds 384 |
| 01/03/2008 | CA2655159A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | CA2654652A1 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | CA2654414A1 Granule and preparation method thereof |
| 01/03/2008 | CA2654394A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/03/2008 | CA2654375A1 Therapeutic compounds |
| 01/03/2008 | CA2654371A1 Therapeutic compounds |
| 01/03/2008 | CA2653726A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | CA2653384A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | CA2647601A1 Pyrrole derivatives and their methods of use |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873158A1 Crystals of morphinan derivative and process for producing the same |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873140A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1873139A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1872790A1 New formulation for increasing bioavailability of neurturin |
| 01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
| 01/02/2008 | EP1872780A2 Omega-Phenyloctanamides as therapeutic compounds |
| 01/02/2008 | EP1872779A1 Stable multiparticulate pharmaceutical composition comprising tri-and tetracyclic antidepressants |
| 01/02/2008 | EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 01/02/2008 | EP1871768A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/02/2008 | EP1871763A1 SUBSTITUTED ARYL 1.4-PYRAZlNE DERIVATIVES |
| 01/02/2008 | EP1871761A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 01/02/2008 | EP1871759A1 Benzodioxane and benzodioxolane derivatives and uses thereof |
| 01/02/2008 | EP1871755A1 Dihydrobenzofuran derivatives and uses thereof |
| 01/02/2008 | EP1871754A1 Dihydrobenzofuran derivatives and uses thereof |
| 01/02/2008 | EP1871752A1 Amidopropoxyphenyl orexin receptor antagonists |
| 01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 01/02/2008 | EP1871748A1 (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1871738A2 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 01/02/2008 | EP1871420A2 Methods of facilitating cell survival using neurotrophin mimetics |
| 01/02/2008 | EP1871403A2 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 01/02/2008 | EP1871390A1 S-adenosyl-l-methionine for regulating behavioral disorders in pets |
| 01/02/2008 | EP1871385A1 Methods for treating visual disorders |
| 01/02/2008 | EP1871382A2 Methods for the treatment of central nervous system injury via a tapered administration of progesterone |
| 01/02/2008 | EP1871369A2 Dihydropyridine compounds and compositions for headaches |
| 01/02/2008 | EP1871368A2 Dihydropyridine compounds for neurodegenerative diseases and dementia |
| 01/02/2008 | EP1871367A2 Compounds for treating inflammatory and demyelinating diseases |
| 01/02/2008 | EP1871363A1 Combined-step process for pharmaceutical compositions |
| 01/02/2008 | EP1871359A1 Delaying the ageing process and disorders caused by ageing |
| 01/02/2008 | EP1871358A1 Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
| 01/02/2008 | EP1871356A1 Dihydrobenzofuran derivatives and uses thereof |
| 01/02/2008 | EP1871355A1 New therapeutic combianations for the treatment or prevention of depression |
| 01/02/2008 | EP1871354A1 Treatment of pain |
| 01/02/2008 | EP1871165A2 Method of treating schizophrenia prodrome |
| 01/02/2008 | EP1753760B1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 01/02/2008 | EP1534304B1 An analgesic agent for newborn or fetal subjects |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1392849B1 Yeast screens for agents affecting protein folding |
| 01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | CN101098866A Heteroaromatic quinoline compounds and their use as pde10 inhibitors |
| 01/02/2008 | CN101098861A Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
| 01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |
| 01/02/2008 | CN101098857A Nitro indazole derivatives |
| 01/02/2008 | CN101098687A Method of modulating b cell functioning |
| 01/02/2008 | CN101098686A Glycogen synthase kinase-3 inhibitors |
| 01/02/2008 | CN101098683A Use of 5-ht6 agonist for the treatment and prevention of neurodegenerative disorders |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101096368A Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/02/2008 | CN101096348A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | CN101096347A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | CN101096346A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095948A Use of ulinastain in the preparing of treating and/or preventing sudden arrest of heart beat tritocerebrum damnification medicine |
| 01/02/2008 | CN101095946A Anti-drug liquor for giving up drug-taking and method for preparing the same |
| 01/02/2008 | CN101095925A Medicine for treating facial palsy and method of manufacturing the same and the medicine taking method thereof |
| 01/02/2008 | CN101095922A Chinese traditional medicine composition for treating diabetes peripheral neuritis |
| 01/02/2008 | CN101095907A Chinese patent drug for treating diabetes peripheral neuritis |
| 01/02/2008 | CN101095900A Sichuan chrysanthemum pain-relieving capsule and method for preparing the same |
| 01/02/2008 | CN101095886A Chinese traditional medicine for treating heart neurosis and method for preparing the same |
| 01/02/2008 | CN101095873A Chinese patent medicine for treating diabetes peripheral neuritis |
| 01/02/2008 | CN101095834A Decoction medicine for treating aypnia fantod type chronic bronchitis |
| 01/02/2008 | CN101095817A Chinese traditional medicine preparations for treating diabetes peripheral neuritis |
| 01/02/2008 | CN101095790A Chinese traditional medicine composition for treating anxiety disease and method of making the same |
| 01/02/2008 | CN101095789A Compound Chinese traditional medicine for treating neuropathic pain |
| 01/02/2008 | CN101095756A Wind headache orally disintegrating tablets and method for preparing the same |
| 01/02/2008 | CN101095745A Particles for invigorating the spleen, oral liquid and condensed pills and method for preparing the same and the quality control method |
| 01/02/2008 | CN101095739A Health-care tea for improving sleep function |
| 01/02/2008 | CN101095709A Panax notoginseng floral leaf effervescent tablets and method for preparing the same |
| 01/02/2008 | CN101095703A Process for preparation of ganoderma lucidum propolis |
| 01/02/2008 | CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095698A Probiotics and prebiotics for preventing and treating foetid faeces and foetid faeces poisoning syndrome and the composition preparations thereof |
| 01/02/2008 | CN101095674A Use of bilobalide in the preparation of medicine for treating parkinsonism |
| 01/02/2008 | CN101095663A Nicergoline sustained-release capsules and method for preparing the same |
| 01/02/2008 | CN100358898C Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 01/02/2008 | CN100358897C 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358889C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358875C Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use |